Healthcare provider profile · identity verified

Edward J Szabo, MD

Allopathic & Osteopathic Physicians|Family Medicine · APPLETON, WI · NPI 1093700403

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Edward J Szabo, MD received $17.37 in general payments during 2025 across 1 reported records.

Amgen Inc. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$17.37

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Amgen Inc.	Unresolved — no canonical attribution shown	$17.37	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$17.37	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
OTEZLA Normalized: otezla	Drug	Amgen Inc.	$17.37	1	2025
Source payment records 2025-03-14 · Amgen Inc. · $17.37 · Open Payments source
REPATHA Normalized: repatha	Biological	Amgen Inc.	$17.37	1	2025
Source payment records 2025-03-14 · Amgen Inc. · $17.37 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	607	145
Levothyroxine Sodium	Levothyroxine Sodium	457	97
Amlodipine Besylate	Amlodipine Besylate	407	100
Omeprazole	Omeprazole	357	86
Lisinopril	Lisinopril	329	80
Warfarin Sodium	Warfarin Sodium	269	27
Gabapentin	Gabapentin	245	55
Rosuvastatin Calcium	Rosuvastatin Calcium	244	59
Losartan Potassium	Losartan Potassium	235	64
Metoprolol Succinate	Metoprolol Succinate	231	58
Simvastatin	Simvastatin	224	53
Hydrochlorothiazide	Hydrochlorothiazide	202	56
Eliquis	Apixaban	197	34
Glipizide Er	Glipizide	189	33
Tamsulosin Hcl	Tamsulosin Hcl	167	40
Furosemide	Furosemide	166	38
Escitalopram Oxalate	Escitalopram Oxalate	158	37
Metoprolol Tartrate	Metoprolol Tartrate	157	28
Metformin Hcl	Metformin Hcl	154	40
Famotidine	Famotidine	138	32
Telmisartan	Telmisartan	121	29
Pravastatin Sodium	Pravastatin Sodium	114	31
Potassium Chloride	Potassium Chloride	112	27
Trazodone Hcl	Trazodone Hcl	111	31
Metformin Hcl Er	Metformin Hcl	108	30
Pantoprazole Sodium	Pantoprazole Sodium	108	29
Allopurinol	Allopurinol	103	23
Lorazepam	Lorazepam	100	23
Clonazepam	Clonazepam	99	22
Jardiance	Empagliflozin	99	18
Sertraline Hcl	Sertraline Hcl	96	20
Januvia	Sitagliptin Phosphate	84	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	81	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	16
Alendronate Sodium	Alendronate Sodium	73	24
Albuterol Sulfate Hfa	Albuterol Sulfate	69	33
Fluticasone Propionate	Fluticasone Propionate	65	20
Zolpidem Tartrate	Zolpidem Tartrate	60	12
Bupropion Xl	Bupropion Hcl	58	13
Carvedilol	Carvedilol	57	17
Lovastatin	Lovastatin	56	12
Meloxicam	Meloxicam	56	18
Memantine Hcl	Memantine Hcl	54	11
Ketoconazole	Ketoconazole	51	28
Lansoprazole	Lansoprazole	51	suppressed
Spironolactone	Spironolactone	50	12
Alprazolam	Alprazolam	49	15
Ozempic	Semaglutide	49	suppressed
Glimepiride	Glimepiride	48	12
Tizanidine Hcl	Tizanidine Hcl	48	23
Montelukast Sodium	Montelukast Sodium	47	17
Doxycycline Hyclate	Doxycycline Hyclate	45	43
Duloxetine Hcl	Duloxetine Hcl	44	11
Hydrocortisone	Hydrocortisone	44	14
Synthroid	Levothyroxine Sodium	42	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	11
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Fenofibrate	Fenofibrate	38	suppressed
Mounjaro	Tirzepatide	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	11
Midodrine Hcl	Midodrine Hcl	36	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Pregabalin	Pregabalin	36	suppressed
Tramadol Hcl	Tramadol Hcl	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	28
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	11
Meclizine Hcl	Meclizine Hcl	33	16
Propranolol Hcl	Propranolol Hcl	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Amoxicillin	Amoxicillin	31	22
Bupropion Hcl	Bupropion Hcl	31	suppressed
Finasteride	Finasteride	31	suppressed
Clonidine Hcl	Clonidine Hcl	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Cephalexin	Cephalexin	29	28
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	25
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Sucralfate	Sucralfate	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Prednisone	Prednisone	26	20
Xarelto	Rivaroxaban	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Nystatin	Nystatin	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	11
Benazepril Hcl	Benazepril Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Methylprednisolone	Methylprednisolone	19	17
Nifedipine Er	Nifedipine	19	suppressed
Nitroglycerin	Nitroglycerin	19	16
Buspirone Hcl	Buspirone Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	16
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Methenamine Hippurate	Methenamine Hippurate	17	suppressed
Ondansetron Odt	Ondansetron	17	14
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Atenolol	Atenolol	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Fosinopril Sodium	Fosinopril Sodium	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Ciclopirox	Ciclopirox	14	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Anastrozole	Anastrozole	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Colchicine	Colchicine	12	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Naratriptan Hcl	Naratriptan Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11
Valacyclovir	Valacyclovir Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$17.37 · 1 records	Amgen Inc.	OTEZLA, REPATHA	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error